Afamelanotide

Modify Date: 2024-01-13 16:06:33

Afamelanotide structure	Common Name	Afamelanotide
	CAS Number	1566590-77-9	Molecular Weight	1706.897
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₈₀H₁₁₅N₂₁O₂₁	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Afamelanotide

Melanotan I acetate is a potent non-selective melanocortin receptor (MCR) agonist. Melanotan I acetate is a synthetic analogue of α-melanocyte stimulating hormone (α-MSH) that stimulates melanogenesis. Melanotan I acetate can induce skin tanning by mimicking the actions of a-MSH on the melanocortin type 1 receptors (MC1R) of melanocytes. Melanotan I acetate can be used for sunlight-induced skin cancers research[1][2][3].

Name	Afamelanotide

Description	Melanotan I acetate is a potent non-selective melanocortin receptor (MCR) agonist. Melanotan I acetate is a synthetic analogue of α-melanocyte stimulating hormone (α-MSH) that stimulates melanogenesis. Melanotan I acetate can induce skin tanning by mimicking the actions of a-MSH on the melanocortin type 1 receptors (MC1R) of melanocytes. Melanotan I acetate can be used for sunlight-induced skin cancers research[1][2][3].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> GPCR/G Protein >> Melanocortin Receptor
References	[1]. Reid C, et al. Atypical melanocytic naevi following melanotan injection. Ir Med J. 2013 May;106(5):148-9. [2]. Bhardwaj R, et al. Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407. J Pharm Sci. 1996 Sep;85(9):915-9.

Description

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> GPCR/G Protein >> Melanocortin Receptor

References

[1]. Reid C, et al. Atypical melanocytic naevi following melanotan injection. Ir Med J. 2013 May;106(5):148-9.

[2]. Bhardwaj R, et al. Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407. J Pharm Sci. 1996 Sep;85(9):915-9.